G-Soft-CL Suppository is a combination pharmaceutical formulation containing Clindamycin 100 mg and Clotrimazole 200 mg, designed for the treatment of mixed vaginal infections caused by susceptible bacterial and fungal pathogens. Clindamycin, a lincosamide antibiotic, exerts its bacteriostatic effect by inhibiting bacterial protein synthesis, effectively targeting anaerobic bacteria commonly implicated in bacterial vaginosis. Clotrimazole, an imidazole antifungal agent, disrupts the fungal cell membrane by inhibiting ergosterol synthesis, thereby exerting potent antifungal activity against Candida species and other pathogenic fungi. The suppository form allows for localized delivery, maximizing drug concentration at the site of infection while minimizing systemic absorption and associated side effects. G-Soft-CL Suppository is indicated for the treatment of mixed vaginal infections, including bacterial vaginosis and vulvovaginal candidiasis, particularly when both bacterial and fungal pathogens are involved. It is generally well-tolerated; however, patients may experience mild local irritation, itching, or discomfort. Use is contraindicated in individuals with known hypersensitivity to clindamycin, clotrimazole, or any excipients. Proper administration involves insertion of one suppository intravaginally, preferably at bedtime, for the duration prescribed by a healthcare professional. This combination therapy offers a comprehensive approach to managing complex vaginal infections, improving clinical outcomes and patient comfort.